- Details
- Description
-
Packaging Sizepackaging size
-
Strength100mg-1vial
-
CompositonRemdesivir
-
TreatmentCOVID-19
-
FormLyophilized powder
-
BrandNinavir
-
Quantity Unit10
-
ManufacturerIncepta Pharma
Remdesivir is an antiviral medication that targets a range of viruses. It was originally developed over a decade ago to treat hepatitis C and a cold-like virus called respiratory syncytial virus (RSV). Remdesivir wasn’t an effective treatment for either disease. But it showed promise against other viruses.
Remdesivir is used to treat people with coronavirus disease 2019 (COVID-19) who are in a hospital.
Remdesivir is approved for use in adults and children at least 12 years old who weigh at least 88 pounds (40 kilograms).
The US Food and Drug Administration (FDA) has authorized emergency use of remdesivir in children younger than 12 years old who weigh at least 8 pounds (3.5 kg) and are hospitalized with COVID-19. Remdesivir has not been FDA-approved to treat COVID-19 in these younger patients, especially outside of a hospital.
